Here’s what you should note:
1. Over the past seven years, the 70 executives have made $9.8 billion combined.
2. Per year, this figure averages to approximately $20 million per CEO.
3. Pharmaceutical company Gilead Sciences former CEO John Martin made $863 million one year, surpassing the pay of any CEO in that timeframe.
4. CEOs made slightly less in 2016 compared to the year prior. In 2015, the 70 executives made $2 billion, which averages to $28.5 million per CEO.
5. Pharmaceutical and drug-related company CEOs were 11 of the top 20 earnings.
More articles on healthcare:
Analysts bearish on Surgery Partners — 4 insights
HCA outpatient surgery cases down 0.2% in Q2: 7 things to know
Candor Healthcare buys ASC operations from Kansas medical group: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
